A
A

Amgen

交易方向

交易者脈動

技術摘要

小時

財經新聞

Looming obesity drug rivalry not a concern for Novo CEO

By Natalie Grover and Maggie Fick LONDON, Nov 15 (Reuters) - The benefits of obesity drugs such as Novo Nordisk's Wegovy on healthcare systems in countries such as the United States are so significant that the expected entry of rival drugs will not hurt its margins, CEO Lars Jorgensen told Reuters on Tuesday. The Danish drugmaker NOVOb.CO raised its full-year earnings outlook earlier this month, after reporting better-than-expected quarterly profit driven by strong sales of its diabetes treatmen
A

Wall St climbs over 1% as midterm election begins; Amgen hits record high

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Take-Two, Lyft slump on downbeat forecasts * Amgen climbs on cholesterol drug data * Indexes up: Dow 1.58%, S&P 1.23%, Nasdaq 1.46% By Amruta Khandekar and Devik Jain Nov 8 (Reuters) - U.S. stock indexes rose for the third straight session on Tuesday as voting began in the crucial midterm election that will determine control of Congress, with investors hoping for a political gridlock wh
A
U
U

S&P 500, Nasdaq end lower; BoE comments add to market jitters late

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Amgen jumps on report of Morgan Stanley upgrade * IMF expects U.S. growth this year to be a meager 1.6% (Updates to close) By Caroline Valetkevitch NEW YORK, Oct 11 (Reuters) - The S&P 500 and Nasdaq ended lower on Tuesday, with indications from the Bank of England that it would support the country's bond market for just three more days adding to market jitters.
A
U
U

Dow, S&P 500 rise after recent losses; investors prepare for inflation, earnings data

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * CBOE Volatility index hovers near two-week highs * Amgen jumps on report of Morgan Stanley upgrade * IMF expects U.S. growth this year to be a meager 1.6% * Indexes: Dow up 1.1%, S&P up 0.4%, Nasdaq down 0.1% By Caroline Valetkevitch NEW YORK, Oct 11 (Reuters) - The Dow and S&P 500 were higher in late afternoon trading Tuesday as investors snapped up some beaten-down shares, but volatility w
A
U
U

S&P 500, Nasdaq fall on fears of profit hit from inflation, rate hikes

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Megacap growth companies fall as yields rise * CBOE Volatility index hovers near two-week highs * Amgen jumps on report of Morgan Stanley upgrade * IMF expects U.S. growth this year to be a meager 1.6% * Indexes: Dow up 0.65%, S&P down 0.08%, Nasdaq down 0.37% By Shreyashi Sanyal Oct 11 (Reuters) - The S&P 500 and the Nasdaq fell on Tuesday in the run-up to a key inflation reading and the st
A
U
U

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

我們運用 cookies 提供您最佳之網頁使用經驗。更改您的cookie 設定跟詳情。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明